Island Pharmaceuticals Limited (ASX:ILA) Directors Insider Transactions
The Directors and Chief Executives of Island Pharmaceuticals Limited (ASX:ILA) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Island Pharmaceuticals Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Island Pharmaceuticals Limited to the ASX stock exchange.
An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.
Island Pharmaceuticals Limited Directors/Insider Transactions Activity
List of Insider trades activity from Island Pharmaceuticals Limited (ILA).
| Date | Director | Director's Title | Shares | Value | Note |
|---|---|---|---|---|---|
| 03 Dec 2025 | Carroll (Jason Alan) | Non Executive Chairman | 974,930 | 45,041 | Exercise at price 0.05 per share. |
| 03 Dec 2025 | Ntoumenopoulos (Christopher) | Director (Non-Executive) | 844,568 | - | - |
| 30 Oct 2025 | Foster (David Charles) | Chief Executive Officer | 160,000 | 15,712 | Other at price 0.10 per share. |
| 30 Oct 2025 | Ntoumenopoulos (Christopher) | Director (Non-Executive) | 346,666 | 34,042 | Other at price 0.10 per share. |
| 24 Jul 2025 | Carroll (Jason Alan) | Non Executive Chairman | 124,250 | 13,916 | Purchase at price 0.11 per share. |
| 02 Jul 2025 | Carroll (Jason Alan) | Non Executive Chairman | 30,975,750 | - | - |
| 02 Jul 2025 | Lynch (Phillip Randolph) | Former | 340,000 | - | - |
| 19 Mar 2025 | Lynch (Phillip Randolph) | Executive Chairman | 80,000 | 3,048 | Exercise at price 0.04 per share. |
| 05 Mar 2025 | Foster (David Charles) | Director (Executive) | 500,000 | 19,000 | Exercise at price 0.04 per share. |
| 12 Feb 2025 | Foster (David Charles) | Director (Executive) | 20,588 | 774 | Exercise at price 0.04 per share. |
| 28 Jan 2025 | Hansen (Albert) | Former | 11,104,034 | - | - |
| 19 Nov 2024 | Lynch (Phillip Randolph) | Executive Chairman | 260,000 | - | - |
| 19 Nov 2024 | MacLeman (Paul) | Former | 118,625 | - | - |
| 19 Sep 2024 | Brookes (David Lionel) | Retired | 100,000 | - | - |
| 19 Jun 2024 | Foster (David Charles) | Director (Executive) | 20,588 | 823 | Exercise at price 0.04 per share. |
| 26 Mar 2024 | Brookes (David Lionel) | Director (Non-Executive) | 40,000 | 1,564 | Other at price 0.04 per share. |
| 26 Mar 2024 | Foster (David Charles) | Director (Executive) | 520,588 | - | - |
| 26 Mar 2024 | Hansen (Albert) | Director (Non-Executive) | 166,667 | 6,516 | Other at price 0.04 per share. |
| 26 Mar 2024 | Lavelle (Anna Ph.D.) | Director (Non-Executive) | 40,000 | 1,564 | Other at price 0.04 per share. |
| 26 Mar 2024 | MacLeman (Paul) | Executive Chairman | 33,572 | 1,312 | Other at price 0.04 per share. |